Literature DB >> 24953950

Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).

Andrej Perdih1, Martina Hrast2, Hélène Barreteau3, Stanislav Gobec2, Gerhard Wolber4, Tom Solmajer5.   

Abstract

Enzymes catalyzing the biosynthesis of bacterial peptidoglycan represent traditionally a collection of highly selective targets for novel antibacterial drug design. Four members of the bacterial Mur ligase family-MurC, MurD, MurE and MurF-are involved in the intracellular steps of peptidoglycan biosynthesis, catalyzing the synthesis of the peptide moiety of the Park's nucleotide. In our previous virtual screening campaign, a chemical class of benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives exhibiting dual MurD/MurE inhibition properties was discovered. In the present study we further investigated this class of compounds by performing inhibition assays on all four Mur ligases (MurC-MurF). Furthermore, molecular dynamics (MD) simulation studies of one of the initially discovered compound 1 were performed to explore its geometry as well as its energetic behavior based on the Linear Interaction Energy (LIE) method. Further in silico virtual screening (VS) experiments based on the parent active compound 1 were conducted to optimize the discovered series. Selected hits were assayed against all Escherichia coli MurC-MurF enzymes in biochemical inhibition assays and molecules 10-14 containing benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole coupled with five member-ring rhodanine moiety were found to be multiple inhibitors of the whole MurC-MurF cascade of bacterial enzymes in the micromolar range. Steady-state kinetics studies suggested this class to act as competitive inhibitors of the MurD enzyme towards d-Glu. These compounds represent novel valuable starting point in the development of novel antibacterial agents.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial agents; Bacterial Mur (MurC–MurF) ligase; Drug design; Linear Interaction Energy (LIE) method; Molecular docking; Molecular dynamics (MD); Structure-based pharmacophores; Virtual screening

Mesh:

Substances:

Year:  2014        PMID: 24953950     DOI: 10.1016/j.bmc.2014.05.058

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization.

Authors:  Andrej Perdih; Martina Hrast; Kaja Pureber; Hélène Barreteau; Simona Golič Grdadolnik; Darko Kocjan; Stanislav Gobec; Tom Solmajer; Gerhard Wolber
Journal:  J Comput Aided Mol Des       Date:  2015-04-08       Impact factor: 3.686

2.  Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis.

Authors:  Kandasamy Eniyan; Anuradha Kumar; Geetha Vani Rayasam; Andrej Perdih; Urmi Bajpai
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

3.  Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases.

Authors:  Martina Hrast; Kaja Rožman; Iza Ogris; Veronika Škedelj; Delphine Patin; Matej Sova; Hélène Barreteau; Stanislav Gobec; Simona Golič Grdadolnik; Anamarija Zega
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 4.  Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen.

Authors:  Arundhati Maitra; Tulika Munshi; Jess Healy; Liam T Martin; Waldemar Vollmer; Nicholas H Keep; Sanjib Bhakta
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

5.  Inhibition of MurA Enzyme from Escherichia coli and Staphylococcus aureus by Diterpenes from Lepechinia meyenii and Their Synthetic Analogs.

Authors:  Macarena Funes Chabán; Martina Hrast; Rok Frlan; Dafni G Graikioti; Constantinos M Athanassopoulos; María Cecilia Carpinella
Journal:  Antibiotics (Basel)       Date:  2021-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.